# NextDecade Corp: financial statements, quarterly

NEXT · Nasdaq · CIK 1612720 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/next.md) · [Financials](/companies/next/financials.md) · [Filings](/companies/next/filings.md) · [Insiders](/companies/next/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/next/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001628280-24-046336.md) | [0.0 d](/filings/0001612720-26-000009.md) | [0.0](/filings/0001628280-25-022731.md) | [0.0](/filings/0001612720-25-000009.md) | [0.0](/filings/0001612720-25-000030.md) | [0.0 d](/filings/0001612720-26-000009.md) | [0.0](/filings/0001612720-26-000026.md) | [0.0](/filings/0001612720-26-000049.md) | [0.0](/filings/0001612720-25-000030.md) | [0.0 d](/filings/0001612720-26-000009.md) | [0.0](/filings/0001612720-26-000026.md) | [0.0](/filings/0001612720-26-000049.md) |
| Research and development | $m | [1.1](/filings/0001628280-24-046336.md) | [2.9 d](/filings/0001612720-26-000009.md) | [2.5](/filings/0001628280-25-022731.md) | [2.4](/filings/0001612720-25-000009.md) | [2.4](/filings/0001612720-25-000030.md) | [1.0 d](/filings/0001612720-26-000009.md) | [0.3](/filings/0001612720-26-000026.md) | [1.2](/filings/0001612720-26-000049.md) | [2.9](/filings/0001612720-25-000030.md) | [3.6 d](/filings/0001612720-26-000009.md) | [2.1](/filings/0001612720-26-000026.md) | [2.9](/filings/0001612720-26-000049.md) |
| Operating income | $m | [(35.8)](/filings/0001628280-24-046336.md) | [(32.1) d](/filings/0001612720-26-000009.md) | [(38.1)](/filings/0001628280-25-022731.md) | [(39.5)](/filings/0001612720-25-000009.md) | [(49.2)](/filings/0001612720-25-000030.md) | [(44.3) d](/filings/0001612720-26-000009.md) | [(51.9)](/filings/0001612720-26-000026.md) | [(56.3)](/filings/0001612720-26-000049.md) | [(72.0)](/filings/0001612720-25-000030.md) | [(45.8) d](/filings/0001612720-26-000009.md) | [(55.1)](/filings/0001612720-26-000026.md) | [(54.6)](/filings/0001612720-26-000049.md) |
| Interest expense | $m | [32.5](/filings/0001628280-24-046336.md) | [17.7 d](/filings/0001612720-26-000009.md) | [25.5](/filings/0001628280-25-022731.md) | [26.0](/filings/0001612720-25-000009.md) | [15.9](/filings/0001612720-25-000030.md) | [20.1 d](/filings/0001612720-26-000009.md) | [27.2](/filings/0001612720-26-000026.md) | [31.6](/filings/0001612720-26-000049.md) | [40.3](/filings/0001612720-25-000030.md) | [70.9 d](/filings/0001612720-26-000009.md) | [79.2](/filings/0001612720-26-000026.md) | [90.8](/filings/0001612720-26-000049.md) |
| Income tax | $m | [0.0](/filings/0001628280-24-046336.md) | not reported | [0.0](/filings/0001628280-24-022756.md) | [0.0 d](/filings/0001628280-24-037219.md) | [0.0](/filings/0001628280-24-046336.md) | not reported | [0.0](/filings/0001612720-26-000026.md) | [0.0](/filings/0001612720-26-000049.md) | not reported | not reported | [0.0](/filings/0001612720-26-000026.md) | [0.0](/filings/0001612720-26-000049.md) |
| Net income | $m | [182](/filings/0001437749-23-031608.md) | [(256) d](/filings/0001612720-26-000009.md) | [187](/filings/0001628280-25-022731.md) | [2.3](/filings/0001612720-25-000009.md) | [(393)](/filings/0001612720-25-000030.md) | [481 d](/filings/0001612720-26-000009.md) | [(245)](/filings/0001612720-26-000026.md) | [(70.6)](/filings/0001612720-26-000049.md) | [(185)](/filings/0001612720-25-000030.md) | [71.0 d](/filings/0001612720-26-000009.md) | [(195)](/filings/0001612720-26-000026.md) | [(60.2)](/filings/0001612720-26-000049.md) |
| Diluted EPS | $ per share | [0.48](/filings/0001628280-24-046336.md) | not reported | [0.11](/filings/0001628280-25-022731.md) | [(0.13)](/filings/0001612720-25-000009.md) | [(0.47)](/filings/0001612720-25-000030.md) | not reported | [(0.34)](/filings/0001612720-26-000026.md) | [(0.23)](/filings/0001612720-26-000049.md) | [(0.42)](/filings/0001612720-25-000030.md) | not reported | [(0.51)](/filings/0001612720-26-000026.md) | [(0.25)](/filings/0001612720-26-000049.md) |
| Basic EPS | $ per share | [0.48](/filings/0001628280-24-046336.md) | not reported | [0.11](/filings/0001628280-25-022731.md) | [(0.13)](/filings/0001612720-25-000009.md) | [(0.47)](/filings/0001612720-25-000030.md) | not reported | [(0.34)](/filings/0001612720-26-000026.md) | [(0.23)](/filings/0001612720-26-000049.md) | [(0.42)](/filings/0001612720-25-000030.md) | not reported | [(0.51)](/filings/0001612720-26-000026.md) | [(0.25)](/filings/0001612720-26-000049.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001437749-23-031608.md) | [0.0](/filings/0001628280-25-008841.md) | [0.0](/filings/0001628280-24-022756.md) | [0.0](/filings/0001628280-24-037219.md) | [0.0](/filings/0001628280-24-046336.md) | [0.1](/filings/0001612720-26-000009.md) | [0.1](/filings/0001628280-25-022731.md) | [0.2](/filings/0001612720-25-000009.md) | [0.2](/filings/0001612720-25-000030.md) | [0.1](/filings/0001612720-26-000049.md) | [0.1](/filings/0001612720-26-000026.md) | [0.1](/filings/0001612720-26-000049.md) |
| Current assets | $bn | [0.5](/filings/0001437749-23-031608.md) | [0.3](/filings/0001628280-25-008841.md) | [0.3](/filings/0001628280-24-022756.md) | [0.2](/filings/0001628280-24-037219.md) | [0.3](/filings/0001628280-24-046336.md) | [0.4](/filings/0001612720-26-000009.md) | [0.4](/filings/0001628280-25-022731.md) | [0.5](/filings/0001612720-25-000009.md) | [0.8](/filings/0001612720-25-000030.md) | [0.7](/filings/0001612720-26-000049.md) | [0.5](/filings/0001612720-26-000026.md) | [0.6](/filings/0001612720-26-000049.md) |
| Total assets | $bn | [2.9](/filings/0001437749-23-031608.md) | [3.3](/filings/0001628280-25-008841.md) | [4.2](/filings/0001628280-24-022756.md) | [4.8](/filings/0001628280-24-037219.md) | [5.1](/filings/0001628280-24-046336.md) | [6.4](/filings/0001612720-26-000009.md) | [6.9](/filings/0001628280-25-022731.md) | [7.9](/filings/0001612720-25-000009.md) | [10.0](/filings/0001612720-25-000030.md) | [12.4](/filings/0001612720-26-000049.md) | [13.2](/filings/0001612720-26-000026.md) | [15.2](/filings/0001612720-26-000049.md) |
| Current liabilities | $bn | [0.6](/filings/0001437749-23-031608.md) | [0.6](/filings/0001628280-25-008841.md) | [0.5](/filings/0001628280-24-022756.md) | [0.5](/filings/0001628280-24-037219.md) | [0.6](/filings/0001628280-24-046336.md) | [0.6](/filings/0001612720-26-000009.md) | [0.5](/filings/0001628280-25-022731.md) | [0.7](/filings/0001612720-25-000009.md) | [1.2](/filings/0001612720-25-000030.md) | [1.3](/filings/0001612720-26-000049.md) | [1.2](/filings/0001612720-26-000026.md) | [1.7](/filings/0001612720-26-000049.md) |
| Total liabilities | $bn | [2.1](/filings/0001437749-23-031608.md) | [2.6](/filings/0001628280-25-008841.md) | [3.0](/filings/0001628280-24-022756.md) | [3.5](/filings/0001628280-24-037219.md) | [4.1](/filings/0001628280-24-046336.md) | [4.7](/filings/0001612720-26-000009.md) | [5.2](/filings/0001628280-25-022731.md) | [6.0](/filings/0001612720-25-000009.md) | [8.0](/filings/0001612720-25-000030.md) | [10.1](/filings/0001612720-26-000049.md) | [10.9](/filings/0001612720-26-000026.md) | [12.4](/filings/0001612720-26-000049.md) |
| Long-term debt | $bn | [1.4](/filings/0001437749-23-031608.md) | [1.8](/filings/0001628280-25-008841.md) | [2.4](/filings/0001628280-24-022756.md) | [2.8](/filings/0001628280-24-037219.md) | [3.3](/filings/0001628280-24-046336.md) | [3.9](/filings/0001612720-26-000009.md) | [4.5](/filings/0001628280-25-022731.md) | [5.2](/filings/0001612720-25-000009.md) | [6.6](/filings/0001612720-25-000030.md) | [8.5](/filings/0001612720-26-000049.md) | [9.4](/filings/0001612720-26-000026.md) | [10.4](/filings/0001612720-26-000049.md) |
| Current portion of debt | $bn | [0.0](/filings/0001437749-23-031608.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.5](/filings/0001628280-24-046336.md) | [0.3](/filings/0001628280-25-008841.md) | [0.4](/filings/0001628280-25-022731.md) | [0.4](/filings/0001612720-25-000009.md) | [0.7](/filings/0001628280-24-046336.md) | [0.4](/filings/0001612720-26-000009.md) | [0.3](/filings/0001628280-25-022731.md) | [0.3](/filings/0001612720-25-000009.md) | [0.2](/filings/0001612720-25-000030.md) | [0.1](/filings/0001612720-26-000049.md) | [(0.0)](/filings/0001612720-26-000026.md) | [(0.1)](/filings/0001612720-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(11.4) d](/filings/0001628280-24-046336.md) | [(21.0) d](/filings/0001612720-26-000009.md) | [(28.8)](/filings/0001628280-25-022731.md) | [6.0 d](/filings/0001612720-25-000009.md) | [(63.8) d](/filings/0001612720-25-000030.md) | [(8.9) d](/filings/0001612720-26-000009.md) | [(68.8)](/filings/0001612720-26-000026.md) | [(3.9) d](/filings/0001612720-26-000049.md) | [(76.0) d](/filings/0001612720-25-000030.md) | [(20.7) d](/filings/0001612720-26-000009.md) | [(111)](/filings/0001612720-26-000026.md) | [(17.2) d](/filings/0001612720-26-000049.md) |
| Capital expenditure | $m | [944 d](/filings/0001628280-24-046336.md) | [741 d](/filings/0001612720-26-000009.md) | [775](/filings/0001628280-25-022731.md) | [593 d](/filings/0001612720-25-000009.md) | [505 d](/filings/0001612720-25-000030.md) | [695 d](/filings/0001612720-26-000009.md) | [770](/filings/0001612720-26-000026.md) | [732 d](/filings/0001612720-26-000049.md) | [1,358 d](/filings/0001612720-25-000030.md) | [1,987 d](/filings/0001612720-26-000009.md) | [1,177](/filings/0001612720-26-000026.md) | [981 d](/filings/0001612720-26-000049.md) |
| Share repurchases | $m | [9.5 d](/filings/0001628280-24-046336.md) | [0.0 d](/filings/0001612720-26-000009.md) | [0.1](/filings/0001628280-25-022731.md) | [0.1 d](/filings/0001612720-25-000009.md) | [6.4 d](/filings/0001612720-25-000030.md) | [0.1 d](/filings/0001612720-26-000009.md) | [0.0](/filings/0001612720-26-000026.md) | [0.0 d](/filings/0001612720-26-000049.md) | [15.5 d](/filings/0001612720-25-000030.md) | [1.4 d](/filings/0001612720-26-000009.md) | [0.0](/filings/0001612720-26-000026.md) | [0.0 d](/filings/0001612720-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [129](/filings/0001437749-23-031608.md) | [147](/filings/0001628280-24-022756.md) | [151](/filings/0001628280-24-037219.md) | [222](/filings/0001628280-24-046336.md) | [267](/filings/0001628280-25-022731.md) | [258](/filings/0001612720-25-000009.md) | [259](/filings/0001612720-25-000030.md) | [260](/filings/0001612720-26-000026.md) | [261](/filings/0001612720-26-000049.md) | [263](/filings/0001612720-25-000030.md) | [265](/filings/0001612720-26-000026.md) | [265](/filings/0001612720-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 266,185,433 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001612720-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.